Source:http://linkedlifedata.com/resource/pubmed/id/16107838
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7053
|
pubmed:dateCreated |
2005-8-18
|
pubmed:abstractText |
Liver transplantation is a life-saving therapy to correct liver failure, portal hypertension and hepatocellular carcinoma arising from hepatitis C infection. But despite the successful use of living donors and improvements in immunosuppression and antiviral therapy, organ demand continues to outstrip supply and recurrent hepatitis C with accelerated progression to cirrhosis of the graft is a frequent cause of graft loss and the need for retransplantation. Appropriate selection of candidates and timing of transplantation, coupled with better pre- and post-transplant antiviral therapy, are needed to improve outcomes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1476-4687
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
18
|
pubmed:volume |
436
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
973-8
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading | |
pubmed:year |
2005
|
pubmed:articleTitle |
Hepatitis C and liver transplantation.
|
pubmed:affiliation |
Department of Medicine, and Center for Liver Disease and Transplantation, Columbia University College of Physicians and Surgeons, 622 West 168th Street, New York, New York 10032, USA. rb464@columbia.edu
|
pubmed:publicationType |
Journal Article,
Review
|